J. PaulDuicMD

PubMed

• An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US.
  Charles Cobbs, Edward McClay, J. Paul Duic, L. Burt Nabors, Donna Morgan Murray, Santosh Kesari> ;CNS oncology. 2019 Mar 1
• In-111 DTPA ommaya cisternography with delayed radiotracer activity demonstrated in the peritoneal cavity.
  Scalcione LR, Katz DS, Duic PJ, Grewal J, Yung EY> ;Clinical nuclear medicine.
• Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
  Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP,...> ;Journal of translational medicine. 2018-06-29
• First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
  Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP,...> ;Journal of translational medicine. 2018-05-29
• Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
  Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perr...> ;The Lancet. Oncology. 2017-08-23
• Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient.
  Duic JP, Grewal J, McConie K, Staszewski H, Haas J, Kesari S> ;Journal of neuro-oncology. 2011-08-11
• 7 citations
  Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.
  Iwamoto, F. M., Kreisl, T. N., Kim, L., Duic, J. P., Butman, J. A., Albert, P. S., Fine, H. A.> ;Cancer. 2010 Feb 10
• A phase I trial of enzastaurin in patients with recurrent gliomas.
  Kreisl TN, Kim L, Moore K, Duic P, Kotliarova S, Walling J, Musib L, Thornton D, Albert PS, Fine HA> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2009-05-05
• Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.
  Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I, Garren N, Mackey M, Butman JA, Camphausen K, Park J, Albert PS, Fine HA> ;Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008-12-29
• 4 citations
  A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors.
  Fine, H. A., Kim, L., Albert, P. S., Duic, J. P., Ma, H., Zhang, W., Tohnya, T., Figg, W. D., Royce, C.> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Dec 7
• Join now to see all